30 years of historical data (1996–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Healthcare Services Group, Inc. trades at 26.9x earnings, 13% above its 5-year average of 23.8x, sitting at the 50th percentile of its historical range. Compared to the Healthcare sector median P/E of 23.7x, the stock trades at a premium of 13%. On a free-cash-flow basis, the stock trades at 12.0x P/FCF, 55% below the 5-year average of 27.0x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.7B | $1.4B | $860M | $771M | $892M | $1.3B | $2.1B | $1.8B | $3.0B | $3.9B | $2.9B |
| Enterprise Value | $1.6B | $1.3B | $791M | $760M | $899M | $1.3B | $2.0B | $1.8B | $3.0B | $3.9B | $2.9B |
| P/E Ratio → | 26.88 | 23.60 | 21.92 | 19.94 | 26.09 | 27.37 | 21.29 | 27.95 | 35.87 | 44.30 | 37.30 |
| P/S Ratio | 0.91 | 0.76 | 0.50 | 0.46 | 0.53 | 0.81 | 1.19 | 0.99 | 1.49 | 2.10 | 1.84 |
| P/B Ratio | 2.59 | 2.27 | 1.72 | 1.69 | 2.09 | 2.95 | 4.37 | 3.94 | 6.80 | 9.80 | 8.49 |
| P/FCF | 12.02 | 10.04 | 35.14 | 20.24 | — | 42.44 | 9.87 | 20.33 | 39.92 | 1755.32 | 80.04 |
| P/OCF | 11.54 | 9.63 | 27.91 | 17.72 | — | 35.94 | 9.67 | 19.38 | 37.46 | 513.71 | 69.52 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Healthcare Services Group, Inc.'s enterprise value stands at 24.0x EBITDA, 63% above its 5-year average of 14.7x. The Healthcare sector median is 13.8x, placing the stock at a 73% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.70 | 0.46 | 0.45 | 0.53 | 0.78 | 1.12 | 0.99 | 1.49 | 2.11 | 1.83 |
| EV / EBITDA | 23.98 | 19.61 | 11.66 | 11.02 | 15.21 | 16.25 | 13.66 | 19.75 | 27.41 | 29.06 | 22.79 |
| EV / EBIT | 32.27 | 26.39 | 13.32 | 12.48 | 18.91 | 19.14 | 15.16 | 20.48 | 29.14 | 29.37 | 23.93 |
| EV / FCF | — | 9.20 | 32.33 | 19.96 | — | 40.76 | 9.30 | 20.33 | 39.98 | 1766.88 | 79.37 |
Margins and return-on-capital ratios measuring operating efficiency
Healthcare Services Group, Inc. earns an operating margin of 2.6%. ROE of 10.6% is modest. ROIC of 7.7% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.0% | 13.0% | 13.3% | 12.8% | 11.4% | 14.0% | 15.2% | 12.4% | 11.8% | 13.6% | 14.3% |
| Operating Margin | 2.6% | 2.6% | 3.1% | 3.3% | 2.6% | 3.9% | — | 4.2% | 5.0% | 6.8% | 7.5% |
| Net Profit Margin | 3.2% | 3.2% | 2.3% | 2.3% | 2.0% | 3.0% | 5.6% | 3.5% | 4.2% | 4.7% | 5.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.6% | 10.6% | 8.3% | 8.7% | 7.8% | 10.4% | 21.0% | 14.3% | 19.9% | 23.9% | 24.4% |
| ROA | 7.3% | 7.3% | 4.9% | 5.0% | 4.6% | 6.1% | 12.9% | 9.1% | 12.2% | 14.6% | 15.3% |
| ROIC | 7.7% | 7.7% | 9.1% | 9.3% | 7.9% | 12.7% | — | 12.9% | 17.3% | 25.7% | 30.5% |
| ROCE | 7.8% | 7.8% | 8.8% | 9.7% | 7.7% | 10.5% | — | 14.0% | 19.6% | 27.6% | 29.0% |
Solvency and debt-coverage ratios — lower is generally safer
Healthcare Services Group, Inc. carries a Debt/EBITDA ratio of 0.3x, which is very conservative (90% below the sector average of 3.1x). The company holds a net cash position — cash of $125M exceeds total debt of $19M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.03 | 0.10 | 0.08 | 0.04 | 0.03 | 0.06 | 0.07 | 0.09 | — |
| Debt / EBITDA | 0.30 | 0.30 | 0.24 | 0.63 | 0.56 | 0.23 | 0.12 | 0.29 | 0.27 | 0.26 | — |
| Net Debt / Equity | — | -0.19 | -0.14 | -0.02 | 0.02 | -0.12 | -0.26 | -0.00 | 0.01 | 0.06 | -0.07 |
| Net Debt / EBITDA | -1.77 | -1.77 | -1.01 | -0.15 | 0.12 | -0.67 | -0.85 | -0.01 | 0.04 | 0.19 | -0.19 |
| Debt / FCF | — | -0.83 | -2.81 | -0.28 | — | -1.69 | -0.58 | -0.01 | 0.05 | 11.57 | -0.66 |
| Interest Coverage | — | — | 8.27 | 6.96 | 14.66 | 46.31 | — | 22.51 | 32.40 | 93.10 | — |
Net cash position: cash ($125M) exceeds total debt ($19M)
Short-term solvency ratios and asset-utilisation metrics
Healthcare Services Group, Inc.'s current ratio of 3.38x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 2.64x to 3.38x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.38 | 3.38 | 2.89 | 2.64 | 2.85 | 2.86 | 3.53 | 3.47 | 3.11 | 2.86 | 4.11 |
| Quick Ratio | 3.28 | 3.28 | 2.80 | 2.55 | 2.73 | 2.72 | 3.33 | 3.22 | 2.86 | 2.63 | 3.74 |
| Cash Ratio | 0.99 | 0.99 | 0.71 | 0.68 | 0.68 | 0.97 | 1.63 | 0.79 | 0.63 | 0.45 | 0.91 |
| Asset Turnover | — | 2.31 | 2.10 | 2.08 | 2.35 | 2.09 | 2.22 | 2.52 | 2.90 | 2.76 | 2.96 |
| Inventory Turnover | 95.12 | 95.12 | 88.82 | 78.83 | 70.73 | 54.25 | 47.25 | 44.17 | 42.76 | 38.04 | 35.44 |
| Days Sales Outstanding | — | 62.09 | 81.34 | 83.75 | 72.73 | 67.18 | 52.97 | 67.60 | 62.11 | 74.07 | 63.36 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Healthcare Services Group, Inc. returns 3.7% to shareholders annually primarily through share buybacks. The earnings yield of 3.7% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | 7.1% | 4.7% | 2.9% | 3.2% | 1.9% | 1.4% | 1.9% |
| Payout Ratio | — | — | — | — | 185.1% | 128.2% | 61.5% | 91.3% | 68.5% | 62.6% | 68.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.7% | 4.2% | 4.6% | 5.0% | 3.8% | 3.7% | 4.7% | 3.6% | 2.8% | 2.3% | 2.7% |
| FCF Yield | 8.3% | 10.0% | 2.8% | 4.9% | — | 2.4% | 10.1% | 4.9% | 2.5% | 0.1% | 1.2% |
| Buyback Yield | 3.7% | 4.4% | 0.6% | 1.5% | 0.0% | 1.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 3.7% | 4.4% | 0.6% | 1.5% | 7.1% | 6.3% | 2.9% | 3.2% | 1.9% | 1.4% | 1.9% |
| Shares Outstanding | — | $73M | $74M | $74M | $74M | $75M | $75M | $75M | $75M | $74M | $73M |
Compare HCSG with 6 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| HCSGYou | $2B | 26.9 | 24.0 | 12.0 | 13.0% | 2.6% | 10.6% | 7.7% | 0.3 |
| SOLV | $13B | 8.4 | 7.8 | — | 53.5% | 26.2% | 38.9% | 16.9% | 2.3 |
| AMN | $987M | -5.1 | 29.2 | 4.1 | 30.8% | -3.4% | -19.1% | -3.9% | 15.4 |
| CCRN | $281M | -19.8 | 319.8 | 2.5 | 20.4% | -1.3% | -3.3% | -3.2% | 6.1 |
| CCEL | $27M | 67.4 | 10.0 | 7.5 | 75.2% | 10.9% | — | — | 3.3 |
| AMS | $14M | 6.4 | 7.7 | — | 32.4% | -9.9% | 7.8% | -5.8% | 6.9 |
| SYRA | $60000 | -0.2 | — | — | 20.7% | -47.2% | -109.1% | -294.7% | — |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how HCSG stacks up against sector leader Solventum Corporation.
Start ComparisonHealthcare Services Group, Inc.'s current P/E ratio is 26.9x. The historical average is 29.0x. This places it at the 50th percentile of its historical range.
Healthcare Services Group, Inc.'s current EV/EBITDA is 24.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.9x.
Healthcare Services Group, Inc.'s return on equity (ROE) is 10.6%. The historical average is 13.4%.
Based on historical data, Healthcare Services Group, Inc. is trading at a P/E of 26.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Healthcare Services Group, Inc. has 13.0% gross margin and 2.6% operating margin.
Healthcare Services Group, Inc.'s Debt/EBITDA ratio is 0.3x, indicating low leverage. A ratio below 2x is generally considered financially healthy.